Earlier, we demonstrated that the RAC1 splice isoform, RAC1b, can protect cells from mesenchymal transition by TGFβ1 and an increase in TGFβ1 and RAC1-driven cell motility in both PDAC and breast cancer cells [31,32]. This evidence concerns the gene RAC1 and breast carcinoma.